About Vikram Deshpande, MD, MBBS

Dr. Deshpande is a member of the Gastrointestinal Pathology Unit. His research has focused on surgical pathology in the areas of gastrointestinal and connective tissue diseases. His contributions to the field of IgG4-related disease have been instrumental in establishing diagnostic criteria, as well as pioneering new treatments for this disease. Dr. Deshpande has published over 100 peer-reviewed articles, editorials, reviews and book chapters and has been an invited speaker at major national and international pathology meetings. Dr. Deshpande serves on the editorial boards of the Archives of Pathology and Laboratory Medicine, and Diagnostic Histopathology.

Departments, Centers, & Programs:

Clinical Interests:



Pathology Associates
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-726-2967
Fax: 617-726-5915

Medical Education

  • MBBS, Jawaharlal Institute, University of Pondicherry
  • MBBS, Pondicherry University
  • Residency, All India Institute of Medical Sciences
  • Residency, Henry Ford Hospital
  • Fellowship, Mass General Hospital
  • Fellowship, Massachusetts General Hospital

American Board Certifications

  • Cytopathology, American Board of Pathology
  • Anatomic Pathology & Clinical Pathology, American Board of Pathology
  • Anatomic Pathology, American Board of Pathology

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research interests include:

  • The pathology and biology of pancreatic tumors
  • IgG4-related disease.


  • View my most recent publications at PubMed

    1. IgG4 Related Disease of the Head and Neck. Deshpande VHead Neck Pathol. 2015 Mar 25. [Epub ahead of print]
    2. Erratum to: The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology. Ferrone CR, Ting DT, Shahid M, Konstantinidis IT, Sabbatino F, Goyal L, Rice-Stitt T, Mubeen A, Arora K, Bardeesy N, Miura J, Gamblin TC, Zhu AX, Borger D, Lillemoe KD, Rivera MN, Deshpande V. Ann Surg Oncol. 2015 Mar 19. [Epub ahead of print] No abstract available.
    3. YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor Regression. Fitamant J, Kottakis F, Benhamouche S, Tian HS, Chuvin N, Parachoniak CA, Nagle JM, Perera RM, Lapouge M, Deshpande V, Zhu AX, Lai A, Min B, Hoshida Y, Avruch J, Sia D, Campreci?s G, McClatchey AI, Llovet JM, Morrissey D, Raj L, Bardeesy N. Cell Rep. 2015 Mar 10. pii: S2211-1247(15)00173-4. doi: 10.1016/j.celrep.2015.02.027. [Epub ahead of print]